Anti-N-methyl-D-aspartate receptor encephalitis with favorable outcome despite prolonged status epilepticus

Neurocritical Care

Volumn 18, Issue 1, 2013, Pages 89-92

  Finné Lenoir, Xavier ^a   Sindic, Christian ^a   Van Pesch, Vincent ^a   El Sankari, Souraya ^a   De Tourtchaninoff, Marianne ^a   Denays, Roger ^b   Hantson, Philippe ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Centre Hospitalier Regional de Namur   (Belgium)

Author keywords

Anti NMDA receptor antibodies; Encephalitis; Immunosuppressive therapy; Ketamine; Seizure management; Status epilepticus

Indexed keywords

ACICLOVIR; ETIRACETAM; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; OLIGOCLONAL BAND; PHENYTOIN; STEROID; THIOPENTAL; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODY DETECTION; ARTICLE; BRAIN RADIOGRAPHY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ASSESSMENT; COMPLEX PARTIAL SEIZURE; CONSCIOUSNESS DISORDER; CONSCIOUSNESS LEVEL; DIAPHORESIS; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; EPILEPTIC STATE; FATIGUE; FLU LIKE SYNDROME; FOCAL EPILEPSY; FOLLOW UP; GLASGOW COMA SCALE; HUMAN; HYPERAMMONEMIA; HYPERTENSION; LYMPHOCYTE COUNT; MALE; MUSCLE HYPERTONIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OROFACIAL DYSKINESIA; OUTCOME ASSESSMENT; PARESIS; PARESTHESIA; PLASMAPHERESIS; PRIORITY JOURNAL; TACHYCARDIA; TONIC CLONIC SEIZURE; VIRUS ENCEPHALITIS;

ADOLESCENT; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; ANTICONVULSANTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; STATUS EPILEPTICUS; TREATMENT OUTCOME;

EID: 84873480177     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-012-9788-8     Document Type: Article

References (10)

1. Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66:11-8.
2. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091-8.
3. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63-74.
4. Niehusmann P, Dalmau J, Rudlowski C, et al. Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol. 2009;66:458-64.
5. Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25-36.
6. Poloni C, Korff CM, Ricotti V, et al. Severe childhood encephalopathy with dyskinesia and prolonged cognitive disturbances: evidence for anti-N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol. 2009;52:e78-82.
7. De Nayer AR, Mylant N, Sindic CJM. A subacute behavioral disorder in a female adolescent: autoimmune anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Biol Psychiatry. 2009;66:e13-4.
8. Davies G, Irani SR, Coltart C, et al. Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med. 2010;38:679-82.
9. Smith JH, Dhamija R, Moseley BD, et al. N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis. Arch Neurol. 2011;68:1069-72.
10. Prüss H, Holtkamp M. Ketamine successfully terminates malignant status epilepticus. Epilepsy Res. 2008;82:219-22.